Search…

Billion Success BioTech (01061.HK) Subsidiary Approved for Commercialization of Multiple Dose Diatropium Sodium Eye Drops in China

24/07/2025

Infortmation from the Securities Times App, Yisheng Biotechnology (01061.HK) announced that its wholly-owned subsidiary, Zhuhai Yisheng Biopharmaceutical Co., Ltd., has obtained approval from the National Medical Products Administration to register and commercialize a multi-dose of Dorzolamide Sodium Eye Drops in Mainland China.

Latest

2 m ago

Market news: U.S. federal prosecutors are laying the groundwork for criminal charges against companies and individuals trying to evade U.S. tariffs.

12 m ago

US Treasury Secretary Besen: Almost every week have breakfast with Federal Reserve Chairman Powell.

12 m ago

Market news: Goldman Sachs and Bank of New York Mellon join hands to introduce cryptocurrency technology into the money market funds.

13 m ago

UBS: Maintains a "buy" rating on Coca-Cola and lowers the target price from $86 per share to $84 per share.

14 m ago

International oil prices fell for the fourth consecutive trading day on Wednesday. Vandana Hari, founder of oil market analysis firm Vanda Insights, said, "The downward trend in crude oil prices over the past three trading days seems to have eased slightly, but I don't think the news of a US-Japan trade agreement will bring much upward momentum, as negotiations between the US and the EU reportedly still face obstacles and delays, which will continue to weigh on market sentiment."

See all latest